Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multigene panels in prostate cancer risk assessment.

Evidence report/technology assessment - 1 Jul 2012

Little Julian, Wilson Brenda, Carter Ron, Walker Kate, Santaguida Pasqualina, Tomiak Eva, Beyene Joseph, Raina Parminder

Abstract excerpt

OBJECTIVES: The aim of this review is to identify, synthesize, and appraise the literature on the analytic validity, clinical validity, and clinical utility of commercially available single nucleotide polymorphism (SNP) panel tests for assessing the risk of prostate cancer. DATA SOURCES: MEDLINE®, Cochrane CENTRAL, Cochrane Database of Systematic Reviews, and Embase, from the beginning of each database to October...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Predisposition to Disease
Share to Polymorphism, Single Nucleotide

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Prostatic Neoplasms

Share to Risk Assessment

Source

Open in PubMed Open full text

Identifiers

PMID: 24423032
PMCID: PMC4781158

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multigene panels in prostate cancer risk assessment.PMID 24423032Read ↗

Multigene panels in prostate cancer risk assessment: a systematic review.Semantic proximity Read ↗

Clinical validity and utility of genetic risk scores in prostate cancer.Semantic proximity Read ↗

A genetic-based approach to personalized prostate cancer screening and treatment.Semantic proximity Read ↗

Clinical Multigene Testing for Prostate Cancer.Semantic proximity Read ↗

The role of single nucleotide polymorphisms in predicting prostate cancer risk and therapeutic decision making.Semantic proximity Read ↗

Population-standardized genetic risk score: the SNP-based method of choice for inherited risk assessment of prostate cancer.Semantic proximity Read ↗

When is a genetic test suitable for prime time? Predicting the risk of prostate cancer as a case-example.Semantic proximity Read ↗

Does genotyping of risk-associated single nucleotide polymorphisms improve patient selection for prostate biopsy when combined with a prostate cancer risk calculator?Semantic proximity Read ↗

Toward Informed Selection and Interpretation of Clinical Genomic Tests in Prostate CancerSemantic proximity Read ↗

Plateau effect of prostate cancer risk-associated SNPs in discriminating prostate biopsy outcomes.Semantic proximity Read ↗

Genomic biomarkers in prostate cancerSemantic proximity Read ↗

A comparison of genetic risk score with family history for estimating prostate cancer risk.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.